comparemela.com
Latest Breaking News On - Researchgate andreas kremer - Page 1 : comparemela.com
Seladelpar Reduces Serum IL-31, Improves Pruritus in Patients with Primary Biliary Cholangitis
The post-hoc analysis of the phase 3 ENHANCE study provides the first published evidence of a correlation between decreases in IL-31, bile acids, and pruritus symptoms in PBC following treatment with an investigational agent.
Zurich
Züsz
Switzerland
Researchgate-andreas-kremer
Cymabay-seladelpar
Drug-administration
University-hospital-zurich
Andreas-kremer
Bay-therapeutics
Breakthrough-therapy-designation
New-drug-application
Priority-review
Andreas Kremer, MD, PhD, MHBA: Seladelpar for the Treatment of PBC
Kremer discusses new ad hoc findings from the phase 3 ENHANCE trial showing seladelpar's unique effect on pruritus in patients with PBC.
Switzerland
Boston
Massachusetts
United-states
Zurich
Züsz
Vancouver
British-columbia
Canada
Researchgate-andreas-kremer
Andreas-kremer
University-hospital-zurich
vimarsana © 2020. All Rights Reserved.